Have a glimpse into the future of cancer treatment where an army of your own tiny soldiers fiercely combats the most stubborn cancers, even at late stage. They’re called T cells. My today’s guest has worked on immunotherapies that arm T cells, patient’s own white blood cells with weapons agains tumors to infuse them back to the patient’s body.
Whether you’re an oncologist or a nonspecialist, you may be sure you’ll learn a tonne from this episode.
You’ll hear about
Professor George Coukos is on a mission to find a cure for the most difficult cancers. Trained as an MD and obstetrician-gynaecologist, he studied and researched cell biology and oncology at the University of Pennsylvania, which led to the discovery of spontaneous anti-tumor response in ovarian cancer. Now he leads major oncology research institutions in Lausanne, Switzerland, to develop novel T cell therapy approaches for solid tumors. He’s the director of Department of Oncology at the University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), as well as the local branch of Ludwig Institute for Cancer Research. An esteemed researcher with over 200 publications, known for the development of combinational immune therapies that have been approved for lung, liver, and kidney cancers.
To follow Prof. Coukos and his colleagues' recent developments go to
If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.
The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.